Mar 11 |
TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
|
Mar 6 |
TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress
|
Feb 20 |
TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic
|
Jan 31 |
Transcode Therapeutics regains compliance with Nasdaq listing rules
|
Jan 31 |
Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders’ Equity Requirement and Continued Listing on The Nasdaq Stock Market
|
Jan 29 |
Looking Into TransCode Therapeutics's Recent Short Interest
|
Jan 29 |
TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer
|
Jan 22 |
TransCode Therapeutics Announces Closing of $7.25 Million Public Offering
|
Jan 19 |
TransCode (RNAZ) Down 50% on Issue of New Common Stock
|
Jan 19 |
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
|